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CLINICAL NURSING RESEARCH / November 1999Sowell et al. / HEALTH CARE PROVIDERS’ INFLUENCE
This study examined how women’s relationship with their primary health care
provider (PHP) and their perceptions about how effective their PHPs believe zido-
vudine (AZT) to be in decreasing perinatal transmission related to women’s AZT
beliefs and intentions. It used a cross-sectional design to collect data from 59
HIV-infected African American women. Almost half the women (45%) had given
birth since HIV diagnosis. Most of the babies born to HIV-infected mothers (87%)
were seronegative. Data analysis with Pearson’s r indicated that the quality of
the women’s relationship with their PHP was positively correlated to how impor-
tant the PHP would be in decision making related to AZT therapy. Significant
positive correlation was observed between women’s perceptions about how ef-
fective their PHPs believed AZT to be in decreasing perinatal HIV transmission
and the women’s own beliefs about AZT, their intent to take AZT if pregnant, and
intent to give AZT to a newborn.
Health Care Providers’ Influence
on HIV-Infected Women’s
Beliefs and Intentions
Related to AZT
Therapy
RICHARD L. SOWELL
KENNETH D. PHILLIPS
CAROLYN MURDAUGH
ABBAS TAVOKALI
University of South Carolina
Despite efforts to prevent the spread of HIV infection, the
number of new cases of HIV continues to spiral upward.
Women of reproductive age represent a disproportionately
large number of individuals being diagnosed with HIV/AIDS
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(Centers for Disease Control [CDC], 1998b). This situation has
serious consequences not only for women who become HIV
infected but for their babies if these women become pregnant.
It is estimated that without treatment, 15% to 30% of babies
born to HIV-infected mothers will have HIV (Anastos, Denen-
berg, & Solomon, 1998). Recent research has shown that treat-
ment of mothers during pregnancy with zidovudine (AZT) can
significantly decrease the transmission of HIV from mother to
baby (CDC, 1994; Simonds et al., 1998). The ability to signifi-
cantly decrease the perinatal transmission of HIV offers one of
the few real successes in HIV prevention.
Although there is evidence that antiretroviral drug therapy
(i.e., AZT) can decrease the chances of perinatal transmission
of HIV, many women do not seek or adhere to such therapy dur-
ing pregnancy. Previous research indicates a number of factors
that may influence HIV-infected women’s willingness to take
antiretroviral drugs. These factors include inadequate or incor-
rect information about antiretroviral therapy, a belief that AZT
is not effective or may have adverse side effects or be harmful to
their babies, and the lack of support for drug therapy among
peers (Misener & Sowell, 1998; Smith, Rapkin, Morrison, &
Kammerman, 1997; Sowell & Misener, 1996; Sowell, Seals, et al.,
1996; Williams, 1997). If women lack accurate information
concerning AZT therapy, health care professionals have a
unique opportunity to intervene with appropriate education
that increases the likelihood of women accepting and adhering
to AZT therapy.
Health care professionals should be one of the most impor-
tant sources of treatment information for women with HIV
infection. Past negative experiences with the health care sys-
tem and/or a specific health care provider may cause women to
be suspicious or mistrust health care professionals (Austin &
Dodge, 1992; Gentry, 1993; Mitchell, Tucker, Loftman, & Wil-
liams, 1992; Sowell, Seals, et al., 1996). HIV-infected women
who do not have a trusting relationship with their health care
provider may be less likely to accept advice about treatment
options than women who trust their health care provider
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(Rheiner, 1995). The status of the health care provider as a
treatment expert may overshadow any negative feelings a
woman has about the health care provider, resulting in a will-
ingness to accept prescribed antiretroviral therapies. To date,
there is a paucity of data as to how HIV-infected women’s will-
ingness to accept and adhere to AZT therapy is influenced by
the relationship that exists between the woman and her health
care provider.
PURPOSE AND SIGNIFICANCE
The purpose of this study was to examine how women’s rela-
tionships with their primary health provider (PHP) related to
their beliefs and intentions concerning AZT therapy during
pregnancy. Specifically, did women’s relationships with their
PHP influence the women’s evaluation of the effectiveness of
AZT in preventing perinatal transmission of HIV, their intent to
take AZT if becoming pregnant, and their intent to give AZT to
their newborns for a recommended period of time? In addition,
the study sought to determine if there was a significant rela-
tionship between women’s perceptions of how positively their
PHP viewed AZT therapy during pregnancy and women’s
evaluation of effectiveness of AZT therapy, their intent to take
AZT if becoming pregnant, and their intent to give AZT to their
babies after birth.
A search of the social science and nursing literature revealed
no other studies that examined the potential influence of the
relationship between HIV-infected women and their PHP on
their beliefs about AZT therapy during pregnancy and their
intent to take AZT if becoming pregnant. Furthermore, only one
study could be found that examined the relationship between
physicians’ evaluation of AZT and women’s willingness to take
AZT during pregnancy (Seals, Hennessey, & Sowell, 1996).
Seals and associates, using a series of situational vignettes
related to acceptance and adherence to AZT, found a negative
relationship between physician doubt about AZT therapy dur-
ing pregnancy and women’s willingness to initiate therapy.
Findings of the Seals, Hennessey, et al. (1996) study suggest
that health care professionals may play an important role in
women’s decisions to take or not take AZT during pregnancy.
The current study goes beyond the Seals, Hennessey, et al.
(1996) study in several ways. First, the study expands the
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definition of PHP to include nurses who provide much of the
care to HIV-infected women. Second, it focuses outcome meas-
ures on women’s actual evaluation of the effectiveness and
intent to take AZT. Third, this study examines the correlation
between how positively women viewed their relationship with
their PHP and the women’s attitudes and behaviors related to
AZT therapy.
BACKGROUND
As of December 1998, the Centers for Disease Control and
Prevention (CDC, 1998b) reported that 109,311 women in the
United States have been diagnosed with AIDS. Minority women
represent a disproportionate number of cases in women, with
80,652 African American women having been diagnosed with
HIV/AIDS (CDC, 1998b). Although HIV infection is not moni-
tored by all states, data from 25 states that report names of
HIV-infected individuals as well as those who have AIDS sup-
port that a greater percentage of women (28% vs. 17%) and Afri-
can Americans (57% vs. 45%) are infected with HIV than was
previously indicated (CDC, 1998b).
In contrast to the first cases of HIV/AIDS identified in urban
men, women with HIV/AIDS often live outside of metropolitan
centers and in the South (CDC, 1998a; Lam & Lui, 1994). In
fact, the increased number of HIV/AIDS cases among women
in the South represents one of the largest in the United States
(CDC, 1998b). A review of national HIV/AIDS statistics reveals
that Georgia and South Carolina rank 9th and 10th respec-
tively in AIDS cases among women. As of September 1998, in
Georgia, where only AIDS cases are reported, there have been
2,976 cases of AIDS diagnosed in women (Department of
Human Resources, 1998). In South Carolina, where both HIV
infection and AIDS cases are reported, there have been 3,532
cases of HIV/AIDS (Department of Health and Environmental
Control, 1998).
The majority of women diagnosed with HIV/AIDS are of
reproductive age (16 to 44 years) and a growing number of
these women are being infected through heterosexual activities
(CDC, 1998b). Such trends mean that HIV infection is not only
a growing concern for women but poses a potential risk to chil-
dren born to HIV-infected mothers. There have been 8,280
cases of pediatric AIDS (CDC, 1998b), and it has been
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estimated that more than 7,000 infants are born to mothers
who are HIV infected each year (CDC, 1994). Almost all newly
diagnosed cases of AIDS among children in the United States
can be attributed to perinatal transmission of HIV.
AZT was the first and continues to be one of the most widely
used antiretrovirals to combat HIV infection (Aboulker &
Swart, 1993; Vella et al., 1994; Volberding et al., 1989).
Although not initially recommended for use in pregnant
women, AZT has become the treatment of choice for preventing
perinatal transmission of HIV. In February 1994, the National
Institutes of Health interrupted a clinical trial (ACTG 076) test-
ing the efficacy of AZT during pregnancy to decrease vertical
transmission of HIV. Women receiving the ACTG 076 treatment
protocol took AZT during their pregnancy and administered a
pediatric dose of AZT to their newborns for 6 weeks following
birth. The study was discontinued when a dramatic difference
in perinatal transmission was observed in the treatment group
(8.3% transmission rate) as compared with the control group
(25.5% transmission rate) (CDC, 1994). Based on the ACTG
076 study, the CDC issued recommendations for HIV counsel-
ing and voluntary testing of pregnant women (CDC, 1995).
However, interruption of ACTG 076 left many unanswered
questions concerning AZT therapy that continue to fuel debate
among scientists, ethicists, and consumer advocacy groups.
Central to this debate are issues related to the benefit and
safety of AZT therapy and the ethics of mandatory HIV testing
of pregnant women and newborns with subsequent enforced
antiretroviral therapy (Ayers, Clive, Tucker, Hajian, & De
Miranda, 1996; Dumois, 1995; Institute for Family-Centered
Care, 1994).
Although AZT therapy has been shown to decrease perinatal
transmission of HIV and it has become the standard of care for
HIV-infected pregnant women, there is evidence that many
women do not take AZT during pregnancy (National Institute of
Allergy and Infectious Diseases, 1994; Sowell & Misener,
1996). Some women have inadequate information about HIV
transmission, and the use of AZT therapy to decrease perinatal
transmission (Flaskerud & Thompson, 1991; Sowell & Mise-
ner, 1996; Stewart, 1993). Other women may not believe that
antiretroviral therapy will be beneficial to them or their babies.
In fact, many women continue to perceive AZT as a harmful
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substance based on their own experiences with AZT and its
side effects, and reports from other women with HIV (Balanon,
Fordyce, & Stoneburner, 1990, National Institute of Allergy
and Infectious Diseases, 1994; Sowell, Seals, et al., 1996).
There is evidence that many women with HIV/AIDS are suspi-
cious of the health care system and may not fully trust their
health care provider, making them unwilling to accept AZT
therapy (Austin & Dodge, 1992; Gentry, 1993; Misener & Sowell,
1998; Sowell, Seals, et al., 1996). This may be especially true of
African American women in the Southern United States where
memories of the Tuskegee syphilis experiment remain (Thomas &
Quinn, 1991). Acknowledging the historical treatment of Afri-
can Americans within the health care system, it is not surpris-
ing that Orloff and colleagues (1996) reported that African
American women have the lowest rates of antiretroviral use
during pregnancy.
The literature in health psychology and pharmacology docu-
ments several factors that influence decisions to take medica-
tions or to adhere to a treatment regimen. These factors include
emotional acceptance of the need for and/or benefit of treat-
ment, a belief that the prescribed therapy will be effective in
treating the condition, financial resources to purchase the
medication, social support, communication with health care
providers, and the patient-provider relationship (Burke &
Dunbar-Jacobs, 1995; Ickovics & Meisler, 1997; Rheiner,
1995). Misener and Sowell (1998), in exploring factors that
influenced HIV-infected women’s decisions to take antiretrovi-
rals, found similar results. In that focus group study, HIV-
infected women identified health professionals, beliefs about
antiretrovirals, side effects, and attitudes of peers and family
as important factors influencing their decisions to accept and
adhere to AZT therapy (Misener & Sowell, 1998).
It may be particularly noteworthy that health care providers’
approach to therapy, as well as the relationship between the
patient and provider, has been identified as an important
determinant in decisions to take medications (Erlen & Mellors,
1999; Lewis, Lasack, Lambert, & Connors, 1997). Living with a
chronic illness results in a control shift as patients perceive
limited personal control over their health. In addition, recur-
ring medical treatment augments beliefs in influential or pow-
erful others, namely, the health care professional (Nagy &
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Wolfe, 1983). One view is that surrendering control to powerful
others is adaptive in situations where other persons may influ-
ence the situation (Affleck, Tennen, Pfeiffer, & Fifield, 1987).
There remains limited empirical data regarding the way in
which HIV-infected women’s evaluation of the patient-provider
relationship and provider’s attitude toward AZT therapy during
pregnancy influence women’s beliefs about the effectiveness of
AZT therapy and their intent to adhere to a prescribed AZT
regime if they become pregnant. Such data are needed if health
care providers are to develop HIV treatment and counseling
strategies that are successful in assisting HIV-infected women
in making informed choices about pregnancy and the use of
AZT therapy.
METHOD
This descriptive study used a cross-sectional sample of
HIV-infected women who reside in Georgia and South Carolina
and were at risk for becoming pregnant (i.e., able to become
pregnant and sexually active). Potential participants were
recruited from two HIV/AIDS service organizations cooperat-
ing in the study. Data were collected over a 4-month period
using face-to-face interviews conducted by research assis-
tants. All of the research assistants were extensively trained in
data collection using an interview format. This study extends
previous qualitative research exploring decision making
related to becoming pregnant and use of AZT therapy among
HIV-infected women (Sowell & Misener, 1996).
DATA COLLECTION TOOLS
To ensure cultural appropriateness and relevance of the
study questionnaire, questions and scales used to collect data
were developed with input from the population of interest (i.e.,
HIV-infected women in the South). In prior focus group work
with HIV-infected women in Georgia and South Carolina by the
lead researcher (Sowell, Cohen, Demi, & Moneyham, 1992),
women indicated a preference for direct questions or short
scales. To respect the women’s perspectives, as well as keep the
study questionnaire short to minimize participant burden, sin-
gle item or short scales were used where possible.
342 CLINICAL NURSING RESEARCH / November 1999
 at UNIV OF TENNESSEE on July 27, 2010cnr.sagepub.comDownloaded from 
Demographic data. Demographic data were collected using a
questionnaire that included age, family, household composi-
tion, education, employment, household income, and types of
governmental services received (i.e., social security and food
stamps). Women were asked specifically about the number of
children they have and how many of these children were born
since they became HIV infected. Women reported the HIV
status of their children and whether they had a child who had
died from HIV/AIDS. In addition, women were asked to report
who served as their primary health care provider (i.e., doctor,
nurse, or other).
Relationship With PHP Scale. Women’s evaluation of their
relationship with their primary health care provider was mea-
sured with a 12-item scale developed by Sowell, Cohen, et al.
(1992) in a 3-year longitudinal study of the effect of HIV/AIDS
on women and their families. The scale items were developed
during eight focus groups with HIV-infected women and later
tested using a sample of 264 women with HIV/AIDS. In that
sample, the instrument demonstrated a Cronbach alpha reli-
ability coefficient of .88. To complete the scale, women were
asked to respond to questions related to their relationship with
their PHP using a four-point Likert-type response scale ranging
from strongly disagree to strongly agree. The scale included
items such as: “My primary health care provider always tells
me the truth,” “I can talk to my primary health care provider
about anything that concerns me,” and “I worry about my pri-
mary health care provider keeping information about me confi-
dential.” Items were summed after reverse scoring negatively
worded items for an overall relationship score ranging from 12
to 48.
AZT Effectiveness Scale. How effective women believed AZT
therapy was in preventing the transmission of HIV from mother
to baby during pregnancy was measured using a researcher-
developed three-item scale. Women were instructed to respond
to three statements about the effectiveness of AZT in decreas-
ing perinatal transmission of HIV (i.e., “AZT is very effective in
preventing transmission of HIV from mother to babies”) using
four-point Likert-type response scale ranging from strongly
disagree to strongly agree.
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Health professional importance in AZT decision making. How
important health care professionals/PHPs were in women’s
decisions to take or not take AZT was determined using one
item. This item asked women to report how important health
care professionals would be in their decision to take or not take
AZT. This item was answered using a four-point response for-
mat (not at all important, somewhat important, important, and
very important).
Evaluation of PHP attitude toward AZT. Women’s perceptions
of how positive their PHP was toward AZT therapy during preg-
nancy were assessed with a one-item, five-point scale. Women
were asked to rate how they believed their PHP would feel about
their taking AZT during pregnancy on a five-point scale (with 5
being very positive or definitely wanting you to take AZT and 1
being very negative or not wanting you to take AZT).
Intent. Women’s intent to take AZT if becoming pregnant and
intent to give AZT to their newborn for a recommended period
after birth were measured using two questions. The first ques-
tion asked women to rate on a five-point scale (with 1 being
would not take and 5 being would take) how likely are you to
take AZT if you get pregnant? The second question asked
women to rate on a five-point scale (with 1 being would not give
and 5 being would give) how likely are you to give your newborn
baby AZT for 6 weeks after birth?
PROCEDURE
Research assistants were identified using the input from
personnel of the cooperating AIDS service agencies. All
research assistants were female and had experience working
with women with HIV infection. None of the research assistants
were providing direct services to the women they interviewed.
The research assistants were trained as to the format and pro-
cedures to be used in the study. Selection criteria for potential
participants were being of reproductive age (18 to 45 years),
African American, verified HIV-seropositive status as docu-
mented by HIV testing in their chart, at risk for pregnancy (i.e.,
had not been sterilized or have a permanent contraceptive
344 CLINICAL NURSING RESEARCH / November 1999
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device), sexually active by self-report, able to speak and under-
stand English, and no evidence of dementia. All women who
met the criteria at the cooperating sites were asked to partici-
pate. Women who agreed to participate were interviewed at the
cooperating agencies, in their homes, or at other mutually
agreed on sites. The actual site for the interview was deter-
mined by the women in conjunction with the research assis-
tant and was intended to provide a comfortable setting in which
the women could respond to study questions. Before any ques-
tions were asked, the purpose of the study was emphasized to
each woman and informed consent was obtained. All questions
were read to the women, and their answers were recorded by
the research assistant. Women were paid a $30 honorarium for
their contribution to the study.
SAMPLE
The sample consisted of 59 African American women who
had been diagnosed as HIV infected. Participants in the study
represented women ranging from those newly diagnosed in the
past 3 months to women who had lived with HIV for 5 or more
years. The majority of the women (83%) received health care
through one of five publicly funded clinics. Primary providers
in three of the clinics were Caucasian males, in one of the clin-
ics the provider was an African American female, and in the
fifth clinic, the providers were of diverse gender and ethnicity.
The remaining women received primary health care through a
number of private providers. The women reported their place of
residence as urban (65%), suburban (17.5%), and rural
(17.5%). Women ranged in age from 19 to 45 years (M = 32.5
years, SD = 6.25). More than one half of the women were single
(58.6%), and almost two thirds (63.2%) of the women had a
high school education or higher. Most of the women (76.7%)
reported household incomes of less than $10,000 annually.
Most of the women (81%) reported having at least one child
(range = 1 to 5). Almost one half (44.9%) of the women reported
having had a baby since being diagnosed as HIV infected. Of
those women who had a baby after becoming HIV infected, only
3 (6.7%) reported having an infected baby. Three women (6.7%)
reported that they did not know their baby’s status.
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FINDINGS
Fifty-six women responded to the question asking who pro-
vided their primary health care. Of those who responded, 50
(89.3%) reported their PHP to be a physician and 6 (10.7%)
reported that a nurse provided their primary care. Interest-
ingly, women who identified nurse practitioners as their PHP
(M = 34.33, SD = 4.55) did not score significantly different on
the Relationship With PHP Scale than women whose PHP was a
physician (M = 36.34, SD = 4.67). The number of women identi-
fying a nurse as their PHP was very small making further inves-
tigation necessary. Women reported that they had a relatively
positive relationship with their PHP. Women’s scores on the
Relationship With PHP Scale ranged from 25 to 44 with a mean
score of 35.9 (SD = 4.79). Data analysis showed a Cronbach’s
alpha reliability coefficient of .74 for the scale.
A majority of women evaluated the effectiveness of AZT in the
prevention of perinatal transmission of HIV as being high.
Although individual scores on the Effectiveness of AZT Scale
represented the entire range of possible scores (3 to 12), the
overall group mean score for this scale was 8.3 (SD = 2.44).
Cronbach’s alpha coefficient for internal consistency for the
scale was calculated as .65. This value was judged as accept-
able due to the sample size and the small number of items com-
prising the scale.
Pearson’s r was used to examine the relationship between
women’s relationship with their PHP and how important health
care professionals were in making the decision to accept AZT
therapy, women’s beliefs about the effectiveness of AZT in
decreasing perinatal transmission of HIV, their intent to take
AZT if they became pregnant, and intent to give AZT to a new-
born. Data analysis revealed a significant association between
woman-provider relationship and the level of importance
played by health care professionals in the decision to take AZT
(r = .37, p = .004). The more positive the relationship between
the woman and the PHP was, the more important the PHP was
reported to be in making decisions concerning AZT therapy
(Figure 1).
Also, Pearson’s r was used to examine the relationship of
how positively women perceived their PHP viewed AZT’s effec-
tiveness in decreasing perinatal transmission and their own
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evaluation of AZT effectiveness, their intent to take AZT if they
became pregnant, and intent to give AZT to a newborn. As
shown in Figure 2, a significant positive relationship was found
between women’s perception of how positively her PHP viewed
AZT during pregnancy and their own evaluation of AZT’s effec-
tiveness (r = .37, p = .01), their intent to take AZT if becoming
pregnant (r = .59, p = .001), and intent to give AZT to their new-
borns (r = .48, p = .001).
CLINICAL IMPLICATIONS
This study represents an initial examination of how HIV-
infected women’s relationship with their primary health care
provider and their perception of the care provider’s attitude
toward AZT therapy during pregnancy relate to women’s AZT
attitudes and intentions. Whereas it is acknowledged that
women’s intentions related to AZT therapy cannot be equated
with actual behaviors, intentions represent a necessary first
Sowell et al. / HEALTH CARE PROVIDERS’ INFLUENCE 347
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important health care providers are in making decisions to take
AZT, intent to take AZT if becoming pregnant, and intent to give
AZT to a newborn.
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step in taking an action. Although further research is needed
that includes larger and more diverse samples, as well as mea-
suring actual behavior, this study provides important insights
into the correlation of two aspects of the patient-provider rela-
tionship with AZT beliefs and intention in a group of HIV-
infected African American women.
Previous research has provided conflicting findings related
to how positively persons with HIV/AIDS view health care pro-
fessionals. Although some studies showed that persons with
HIV/AIDS have had negative health seeking experiences (Bing &
Soto, 1991; Siegel & Krauss, 1991; Sowell, Seals, et al., 1996),
researchers exploring factors related to drug adherence
reported that many participants identify their relationship with
their provider as an important influence in their ability to follow
complex treatment regimes (DiMatteo et al., 1993; Powell-
Cope, 1994). Whereas women in the current study viewed their
relationship with their PHP as more positive than negative, the
results suggest that women were not totally satisfied with the
patient-provider relationship or did not fully trust their PHP.
One possible explanation for this finding may lie in the his-
torical treatment of poor and/or minority within the health
care system (Bing & Soto, 1991; Mitchell et al., 1992). All the
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women in this study were African American, potentially adding
an underlying sense of mistrust based on previous experiences
of discrimination encountered within society in their daily lives
(Moneyham et al., 1996; Timmons & Sowell, 1999). In previous
research with a sample of primarily poor minority women in the
South, women described concerns within the health care sys-
tem about confidentiality, being given few options, and not
being able to access services for which they were eligible
(Seals, Sowell, et al., 1995; Sowell, Seals, et al., 1996). Women
with HIV infection, similar to other individuals seeking health
care, need to be educated about their illnesses and potential
therapies and allowed to participate in choosing and managing
treatment options (Taylor, 1991; Ungvarski, 1997; Williams,
1997).
It might be expected that women who had a positive relation-
ship with their PHP would have more positive attitudes and
intentions toward AZT therapy than women who had a negative
relationship with their PHP. However, the findings show that
the relationship between women and their PHP was not signifi-
cantly related to women’s evaluation of AZT effectiveness, their
intent to take AZT if becoming pregnant, or intent to give AZT to
a newborn. This finding may have partially resulted from the
relatively small sample size and the fact that most women had a
somewhat positive relationship with their PHP. A third consid-
eration is that it may not be the actual patient-provider rela-
tionship that influences women’s beliefs and intentions related
to AZT therapy but, rather, the communication and percep-
tions about such therapy that women get within the relation-
ship. Women may have a very positive relationship with their
PHP but that does not necessarily mean that individual provid-
ers adequately communicated information about AZT therapy
or its benefits in decreasing perinatal transmission of HIV.
However, the results did show that how positively women
evaluated their relationship with the PHP was significantly
related to how important the health care providers would be in
making AZT-related decisions. The patient-provider relation-
ship provides the context in which communication about AZT
therapy takes place.
An examination of women’s evaluation of the effectiveness of
AZT as a way to decrease perinatal transmission of HIV showed
that most women view AZT as having value in preventing
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transmission to a baby. However, a group of women indicated
they did not believe AZT was effective in preventing perinatal
transmission. This finding underscores the need for health
care professionals to fully assess women’s attitudes toward
antiretroviral therapy and realize that even if the women feel
compelled to accept therapy, they may not adhere (Sowell,
Seals, et al., 1996).
One of the most important findings in this study supports
the importance of perceptions and communications within the
patient-provider relationship. Although women’s evaluations
of their relationships with their PHP did not relate significantly
to their AZT beliefs and intentions, women’s perceptions of how
positively their PHPs view the use of AZT therapy during preg-
nancy did. Data analysis revealed a significant positive rela-
tionship between how favorably the PHP views AZT as a way of
decreasing perinatal pregnancy and women’s evaluation of AZT
effectiveness in decreasing perinatal transmission, women’s
intent to take AZT if becoming pregnant, and intent to give AZT
to their newborns. This finding underscores the benefit of clear
and honest communications between HIV-infected women and
their PHP. Furthermore, this finding supports the value of
health care professionals going beyond the presentation of
facts and figures in their education and/or counseling of HIV-
infected women. In educating women about AZT therapy dur-
ing pregnancy, it may be equally as important for health care
professionals to communicate a positive personal evaluation of
such therapy as it is to present statistical data from clinical tri-
als such as ACTG 076.
Although intentions to take AZT are influenced by many
relationships, including family and peers, the results of this
study support the importance of the patient-provider relation-
ship in treatment-related decision making. The fact that
women’s AZT beliefs and intentions are significantly related to
their perception of how favorably their PHP views such therapy
provides important data that can be readily integrated into
clinical practice. It is important for PHPs to critically examine
their approach to treating poor women with HIV to ensure that
interactions are respectful, culturally appropriate, and take
into account the importance of women’s perceptions of pro-
vider attitudes in making treatment decisions (Charonko,
1992; Crespo-Fierro, 1997).
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